Differences Anti-Clot Burden and Benefits Treatment Scale (ACTS) and SWAN score (on satisfaction compared to warfarin) between those who were treated with apixaban and rivaroxaban (mean and range).
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://figshare.com/articles/dataset/Differences_Anti-Clot_Burden_and_Benefits_Treatment_Scale_ACTS_and_SWAN_score_on_satisfaction_compared_to_warfarin_between_those_who_were_treated_with_apixaban_and_rivaroxaban_mean_and_range_/12427022
下载链接
链接失效反馈官方服务：
资源简介：
Higher scores reflect greater satisfaction/less burden.
创建时间：
2020-06-04
